Vascular Medcure, Inc.
United StatesFDA applicant, unverified
- Devices
- 5
What Vascular Medcure, Inc. makes
Vascular Medcure, Inc. manufactures the CAPERE Thrombectomy System, a device designed for the mechanical removal of thrombi (blood clots) within blood vessels, primarily used in vascular and neurovascular procedures.
The CAPERE Thrombectomy System is classified as a Class II medical device in the US and is listed under the FDA’s 510(k) pathway. The company is based in the United States.
Catalogue
CAPERE Thrombectomy System Ref K183179
Regimes: 510(k) Registry: 510(k)CAPERE Thrombectomy System Ref K201216
Regimes: 510(k) Registry: 510(k)CAPERE Thrombectomy System Ref K203476
Regimes: 510(k) Registry: 510(k)Capere Thrombectomy System Ref K200314
Regimes: 510(k) Registry: 510(k)CAPERE Thrombectomy System Ref K192935
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Vascular Medcure, Inc. have in the registry?
The registry currently lists 5 devices for Vascular Medcure, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Vascular Medcure, Inc.'s devices?
Among its 5 most recently registered devices, Vascular Medcure, Inc. has devices listed in FDA 510(k) (5 devices).
What risk classes do Vascular Medcure, Inc.'s devices fall under?
Among its 5 most recently registered devices, the classes recorded for Vascular Medcure, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Vascular Medcure, Inc. in the registry?
The most recently registered devices listed for Vascular Medcure, Inc. include CAPERE Thrombectomy System.